Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 174 participants.
Also called NCT02552238
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Phase 3
- Enrolled
- 174 participants
- Sponsor
- Registry
-
NCT02552238
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Belgium, Canada, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02552238. Allocation not applicable; no masking; primary purpose diagnostic. Start 2015-10-12 (actual); primary completion 2017-06-22 (actual). Results posted on 2020-08-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Lumason
- Lead sponsor
- Bracco Diagnostics, Inc
Record details
- Record id
cardio:ct-nct02552238- Content hash
1105c98fd2c7c85b07da905be69e7a7f04df93a28674313d4e3a4adbd7229d49